Cancer Research UK
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 1K
- Market Cap
- -
NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2011-03-28
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 6
- Registration Number
- NCT01324115
- Locations
- 🇬🇧
Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood, England, United Kingdom
Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2010-11-03
- Last Posted Date
- 2013-10-08
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 36
- Registration Number
- NCT01233492
- Locations
- 🇬🇧
Cancer Research UK Clinical Trials Unit - Birmingham, Birmingham, England, United Kingdom
🇬🇧Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 45
- Registration Number
- NCT01222221
- Locations
- 🇬🇧
Addenbrooke's Hospital, Cambridge, England, United Kingdom
🇬🇧Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom
🇬🇧Western General Hospital, Edinburgh, United Kingdom
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer
- Conditions
- Breast CancerColorectal CancerGastric CancerLung CancerOvarian CancerPancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2010-10-01
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 14
- Registration Number
- NCT01212887
- Locations
- 🇬🇧
Christie Hospital, Manchester, England, United Kingdom
Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer
- Conditions
- Gastric CancerHead and Neck CancerLymphomaLymphoproliferative DisorderNonneoplastic Condition
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 16
- Registration Number
- NCT01147991
- Locations
- 🇬🇧
Royal Marsden - London, London, England, United Kingdom
🇬🇧University of Birmingham, Birmingham, England, United Kingdom
🇬🇧Christie Hospital, Manchester, England, United Kingdom
GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2012-05-01
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 35
- Registration Number
- NCT01147029
- Locations
- 🇬🇧
Christie Hospital, Manchester, England, United Kingdom
🇬🇧Churchill Hospital, Oxford, England, United Kingdom
Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Cancer Research UK
- Registration Number
- NCT01132599
- Locations
- 🇬🇧
St. Thomas' Hospital, London, England, United Kingdom
Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2013-05-01
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 38
- Registration Number
- NCT01118611
- Locations
- 🇬🇧
Barts and the London School of Medicine, London, England, United Kingdom
🇬🇧Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2010-04-02
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 44
- Registration Number
- NCT01098344
- Locations
- 🇬🇧
St James' Hospital, Leeds, United Kingdom
🇬🇧Leicester Royal Infirmary, Leicester, England, United Kingdom
🇬🇧Addenbrooke's Hospital, Cambridge, England, United Kingdom
Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2009-10-02
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 8
- Registration Number
- NCT00989105
- Locations
- 🇬🇧
Saint Bartholomew's Hospital, London, England, United Kingdom